Advanced Search
Now showing items 21-30 of 1378
Consumo de lácteos y su asociación con diabetes mellitus tipo 2, hipertensión arterial y obesidad en la población chilena
(Universidad de Chile, 2021)
factores de riesgo para ENT; 34,4% de obesidad, 27,6% de sospecha de
hipertensión arterial (HTA), y 12,3% de sospecha de diabetes mellitus. La dieta
corresponde a uno de los factores clave en la prevención y control de las ENT. A
pesar del variado y...
In 2017, non-communicable diseases (NCDs) account for 73% of all-cause deaths worldwide. In Chile, the results of the National Health Survey (ENS) 2016-2017 show that the population has a high prevalence of risk factors for NCDs; 34.4% are obese, 27.6% have hypertension (HT), and 12.3% have diabetes mellitus type 2 (T2D). Diet corresponds to one of the key factors in the prevention and control of NCDs. Despite the relevance of dairy products on health, there is evidence suggesting that dairy consumption may be linked with poor health outcomes, this may be explained by the amount saturated fat on dairy foods. The relationship between dairy consumption and overweight or obesity, diabetes and HT has been widely studied worldwide and the evidence based on observational and intervention studies, although not conclusive, suggests an inverse or neutral association between dairy consumption and these diseases. However, there are no studies investigating this relationship in the Chilean population. Therefore, the aim of this study is to investigate the association between the consumption of dairy products (milk, cheese, fresh cheese, and yogurt) and the prevalence of obesity, T2D and HT in the Chilean population. This cross-sectional study includes data from the latest National Health Survey (ENS 2016-2017) conducted in Chile. The outcomes were prevalent obesity, T2D and HT. Dairy consumption measured as frequency and types of dairy products consumed was self-reported. Adjusted logistic regression models were conducted to determine the prevalence ratio and 95% confidence intervals. It was observed that the preference for whole fat dairy products was associated with a 47% lower prevalence of T2D in women (PR: 0.53; 95% CI: 0.35-0.80), 29% lower prevalence of abdominal obesity in men (PR: 0.71; 95% CI: 0.52-0.97), and 27% lower prevalence of HT in men (PR: 0.73; 95% CI: 0.57-0.92), after adjusting for covariates. No association was observed between the frequency of dairy consumption and the prevalence of general and abdominal obesity, HT and T2D. Due to the nature of the study, it is not possible to establish a causal association between whole dairy products and a lower prevalence of these diseases. On the other hand, it is possible that people diagnosed by a doctor with HT or T2D have a different preference for whole fat or skimmed dairy products than those who do not have the diagnosis, but are suspected of the pathologies, and that may influence the results of association between the variables. As well as possible confounding variables and dietary factors not included in the analyses....
In 2017, non-communicable diseases (NCDs) account for 73% of all-cause deaths worldwide. In Chile, the results of the National Health Survey (ENS) 2016-2017 show that the population has a high prevalence of risk factors for NCDs; 34.4% are obese, 27.6% have hypertension (HT), and 12.3% have diabetes mellitus type 2 (T2D). Diet corresponds to one of the key factors in the prevention and control of NCDs. Despite the relevance of dairy products on health, there is evidence suggesting that dairy consumption may be linked with poor health outcomes, this may be explained by the amount saturated fat on dairy foods. The relationship between dairy consumption and overweight or obesity, diabetes and HT has been widely studied worldwide and the evidence based on observational and intervention studies, although not conclusive, suggests an inverse or neutral association between dairy consumption and these diseases. However, there are no studies investigating this relationship in the Chilean population. Therefore, the aim of this study is to investigate the association between the consumption of dairy products (milk, cheese, fresh cheese, and yogurt) and the prevalence of obesity, T2D and HT in the Chilean population. This cross-sectional study includes data from the latest National Health Survey (ENS 2016-2017) conducted in Chile. The outcomes were prevalent obesity, T2D and HT. Dairy consumption measured as frequency and types of dairy products consumed was self-reported. Adjusted logistic regression models were conducted to determine the prevalence ratio and 95% confidence intervals. It was observed that the preference for whole fat dairy products was associated with a 47% lower prevalence of T2D in women (PR: 0.53; 95% CI: 0.35-0.80), 29% lower prevalence of abdominal obesity in men (PR: 0.71; 95% CI: 0.52-0.97), and 27% lower prevalence of HT in men (PR: 0.73; 95% CI: 0.57-0.92), after adjusting for covariates. No association was observed between the frequency of dairy consumption and the prevalence of general and abdominal obesity, HT and T2D. Due to the nature of the study, it is not possible to establish a causal association between whole dairy products and a lower prevalence of these diseases. On the other hand, it is possible that people diagnosed by a doctor with HT or T2D have a different preference for whole fat or skimmed dairy products than those who do not have the diagnosis, but are suspected of the pathologies, and that may influence the results of association between the variables. As well as possible confounding variables and dietary factors not included in the analyses....
Manejo Odontológico del pacienye hipertenso
(Sociedad Odontológica de Chile, 2001-08)
El presente artículo es una revisión actualizada sobre la etiopatogenia, los signos y síntomas y el manejo médico de la hipertensión arterial, junto con las consideraciones que el odontólogo debe tener al tratar pacientes hipertensos, así como en el...
Analisis costo-utilidad de un programa para el control de la hipertensión en atención primaria
(Universidad de Chile, 2011)
La principal causa de muerte en Chile es atribuible al sistema cardiovascular donde la hipertensión arterial se comporta como factor de riesgo mayor, con una prevalencia del 26,9%. Si bien, en atención primaria, desde el año 2002 el Estado financia...
Introduction: The main cause of death in Chile it´s relative to cardiovascular disorders, where the Hypertension acts as major risk factor with a prevalence of 26,9%. Although in primary care since 2002 the State finances the cardiovascular health program in Chile, trying to attend this epidemiological reality, there is not an integrated approach, it´s based in pharmacology and the lifestyles modifications are just recommendations and not therapy. Only 2,49% patients receiving non-pharmacological treatment exclusively. This study aims to determinate the cost/utility index for each hypertension control program applied. Methods: We performed a cost-utility study between two alternatives to approach to hypertension. We used population data from the Family Health Center “Colina”. We designed a comprehensive program for the management of these patients including physicians, physiotherapists, nutritionist and nurse. We calculated the costs of implementation and program development and organized into a cash flow to 5 years. We estimated the Disability.-Adjusted Years Life saved by each of the interventions and the cost-utility rate for both. We compared the results of each intervention. Results: The proposed program prevents a total of 0.82 lost years through the reduction of 0.33 lost yrars due to acute myocardial infarction and 0.49 years lost due to stroke. The rate cost/utility of the proposed program is 207.527.280 pesos/lost years saved, resulting in cost/effective. Conclusion: Despite the limitations in representing the behavior of the population, it is recommended to implement a program as suggested in primary care....
Introduction: The main cause of death in Chile it´s relative to cardiovascular disorders, where the Hypertension acts as major risk factor with a prevalence of 26,9%. Although in primary care since 2002 the State finances the cardiovascular health program in Chile, trying to attend this epidemiological reality, there is not an integrated approach, it´s based in pharmacology and the lifestyles modifications are just recommendations and not therapy. Only 2,49% patients receiving non-pharmacological treatment exclusively. This study aims to determinate the cost/utility index for each hypertension control program applied. Methods: We performed a cost-utility study between two alternatives to approach to hypertension. We used population data from the Family Health Center “Colina”. We designed a comprehensive program for the management of these patients including physicians, physiotherapists, nutritionist and nurse. We calculated the costs of implementation and program development and organized into a cash flow to 5 years. We estimated the Disability.-Adjusted Years Life saved by each of the interventions and the cost-utility rate for both. We compared the results of each intervention. Results: The proposed program prevents a total of 0.82 lost years through the reduction of 0.33 lost yrars due to acute myocardial infarction and 0.49 years lost due to stroke. The rate cost/utility of the proposed program is 207.527.280 pesos/lost years saved, resulting in cost/effective. Conclusion: Despite the limitations in representing the behavior of the population, it is recommended to implement a program as suggested in primary care....
Hemodynamic and functional hepatic effects of isosorbide-5-monitrate in cirrhotic patients with portal hypertension Efectos hemodinámicos y funcionales hepáticos del 5-mononitrato de isosorbide en cirróticos con hipertensión portal.
(1993)
hipertensión portal.
Silva,
Fluxá,
Ruiz,
Bresky,
Barrientos,
Backhouse,
Palma,
Iturriaga,
Isosorbide 5-mononitrate reduces portal pressure in acute conditions. The aim of this work was to
assess its effects and tolerance development after 30 days of use...
Morbidity and mortality of essential arterial hypertension treated in Chile: a 15 years' follow-up study Morbimortalidad de la hipertensión arterial esencial tratada en Chile: seguimiento a 15 años.
(1991)
Morbidity and mortality of essential arterial hypertension treated in Chile: a 15
years' follow-up study Morbimortalidad de la hipertensión arterial esencial
tratada en Chile: seguimiento a 15 años.
Román,
Basso...
Recommendations for the management of hypertensive crisis. a consensus document of the Chilean Society of Hypertension Recomendaciones para el manejo de las crisis hipertensivas: Documento de Consenso de la Sociedad Chilena de Hipertensión Arterial
(2002)
Chilena de Hipertensión Arterial
Valdés S, Gloria
Roessler B, Emilio
The management of severe hypertension in the emergency setting demands a careful evaluation of
the different underlying clinical situations, and of the impending risk for the life...
Prevalence of hypertension in school age children and its association with obesity Prevalencia de hipertensión arterial y su asociación con la obesidad en edad pediátrica
(2011)
Prevalence of hypertension in school age children and its association with
obesity Prevalencia de hipertensión arterial y su asociación con la obesidad en
edad pediátrica
Bancalari, Rodrigo
Díaz, Carlos
Martínez...
Actualización en el tratamiento del síndrome de hipertensión intracraneana
(Sociedad Médica de Santiago, Chile, 2022)
Perfil de compra de dispositivos de medición de presión arterial, Chile 2018-2020
(Pan American Health Organization, 2022)
Pharmacological treatment for pulmonary arterial hypertension: availability and access in Latin America and The Caribbean
(Churchill Livingstone Inc Medical Publishers, 2024)